Actually a lot of drugs make it all the way through to approval from Phase I. I think you probably mean preclinical to approval. It's something like 33% across

Actually a lot of drugs make it all the way through to approval from Phase I. I think you probably mean preclinical to approval. It's something like 33% across all therapy areas in the USA, and in some areas closer to 50%.